Program
Pemetrexed
Also written as “pemetrexed”, “ALIMTA” and “Pemetrexed/Cisplatin”.
Its studies are mostly in Carcinoma, Non-Small-Cell Lung · Breast Neoplasms · Neoplasms · Ovarian Neoplasms · Colorectal Neoplasms, led by 9 companies.
Drug pagePemetrexed: every studyMany companies study it; this page follows only the 108 they lead. All 434 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Eli Lilly | 940 open or running | phase 4since Sep 22, 2006 | Apr 29, 2002 | none ahead |
| Hoffmann-La Rocheits history only | 72 open or running | phase 3since Aug 18, 2009 | Aug 18, 2009 | Jun 30, 2027phase 3 · NCT05112965 |
| Betta Pharmaceuticalsits history only | 10 open or running | phase 4since Mar 31, 2014 | Mar 31, 2014 | none ahead |
| Hikma Pharmaceuticalsits history only | 10 open or running | phase 4since Feb 26, 2018 | Feb 26, 2018 | none ahead |
| Johnson & Johnsonits history only | 11 open or running | phase 3since Aug 31, 2020 | Aug 31, 2020 | none ahead |
| NovoCureits history only | 10 open or running | phase 2since Mar 19, 2015 | Mar 19, 2015 | none ahead |
| Polaris Groupits history only | 10 open or running | phase 3since Mar 5, 2016 | Mar 5, 2016 | none ahead |
| Shanghai Miracogenits history only | 11 open or running | phase 3since Feb 22, 2023 | Feb 22, 2023 | none ahead |
| Takedaits history only | 10 open or running | phase 2since Jun 22, 2006 | Jun 22, 2006 | none ahead |
Also a collaborator on its studies: Exelixis, Novartis, Clovis Oncology, Parexel, Daiichi Sankyo, Arcus Biosciences, Ono Pharmaceutical and Prologue Research International.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Eli Lilly only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 43 studies since Sep 12, 2005.
- May 28, 2008Phase 3 study in Carcinoma, Non-Small-Cell LungNCT00686959 · 598 enrolled · United States, Argentina, Australia and more
- Sep 26, 2008Phase 3 study in Carcinoma, Non-Small-Cell LungNCT00762034 · 939 enrolled · United States
- Nov 10, 2008Phase 3 study in Carcinoma, Non-Small-Cell LungNCT00789373 · 939 enrolled · Australia, Belgium, Finland and more
- Mar 20, 2009Phase 2 study in Carcinoma, Non-Small-Cell LungNCT00867009 · 113 enrolled · Austria, Germany, Greece and more
- Apr 23, 2009Phase 2 study in Carcinoma, Non-Small-Cell LungNCT00887549 · 70 enrolled · Ireland, United Kingdom
- Jul 28, 2009Phase 3 study in Carcinoma, Non-Small-Cell LungNCT00948675 · 361 enrolled · United States
- Oct 21, 20092 phase 2 studies in Carcinoma, Non-Small-Cell LungNCT01000480, NCT01004250
- Oct 29, 2009Phase 3 study in Carcinoma, Non-Small-Cell LungNCT01005680 · 256 enrolled · China
- Nov 19, 2009Phase 3 study in Carcinoma, Non-Small-Cell LungNCT01017874 · 236 enrolled · Hong Kong, Korea, Republic of, Singapore and more
- Nov 24, 2009Phase 4 study in Carcinoma, Non-Small-Cell LungNCT01020786 · 109 enrolled · Japan
- Jan 20, 2010Phase 2 study in Head and Neck NeoplasmsNCT01057589 · 66 enrolled · Belgium, France, Germany and more
- Mar 15, 2010Phase 2 study in Head and Neck NeoplasmsNCT01087970 · 69 enrolled · United States
- Jul 8, 20102 phase 2 studies in Carcinoma, Non-Small-Cell LungNCT01160744, NCT01165021
- Nov 2, 20112 phase 2 studies in Carcinoma, Non-Small-Cell LungNCT01473563, NCT01469000
TargetBeta
“Thymidylate synthase inhibitor; Dihydrofolate reductase inhibitor; GAR transformylase inhibitor; Dihydrofolate reductase inhibitor”ChEMBL 37, by rule
Studies
The newest 60 of 94 Eli Lilly leads. Each opens its study page. Every study on its drug page →
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT01469000Carcinoma, Non-Small-Cell Lung · China, Japan, Korea, Republic of and more | 2 | Completed | Apr 2015 | 195 |
| NCT01473563Carcinoma, Non-Small-Cell Lung · Sweden, United Kingdom | 2 | Completed | Sep 2013 | 52 |
| NCT01165021Carcinoma, Non-Small-Cell Lung · Italy | 2 | Completed | Jul 2013 | 19 |
| NCT01160744Carcinoma, Non-Small-Cell Lung · United States, Belgium, Canada and more | 2 | Completed | Jan 2014 | 280 |
| NCT01087970Head and Neck Neoplasms · United States | 2 | Completed | Aug 2013 | 69 |
| NCT01057589Head and Neck Neoplasms · Belgium, France, Germany and more | 2 | Completed | Feb 2012 | 66 |
| NCT01020786Carcinoma, Non-Small-Cell Lung · Japan | 4 | Completed | Mar 2011 | 109 |
| NCT01017874Carcinoma, Non-Small-Cell Lung · Hong Kong, Korea, Republic of, Singapore and more | 3 | Completed | Apr 2013 | 236 |
| NCT01005680Carcinoma, Non-Small-Cell Lung · China | 3 | Completed | Nov 2012 | 256 |
| NCT01004250Carcinoma, Non-Small-Cell Lung · Denmark, Germany, Italy and more | 2 | Completed | Nov 2012 | 109 |
| NCT01000480Carcinoma, Non-Small-Cell Lung · France, Germany, Italy and more | 2 | Completed | Jan 2013 | 90 |
| NCT00948675Carcinoma, Non-Small-Cell Lung · United States | 3 | Completed | Jan 31, 2013 | 361 |
| NCT00887549Carcinoma, Non-Small-Cell Lung · Ireland, United Kingdom | 2 | Completed | Jul 2010 | 70 |
| NCT00867009Carcinoma, Non-Small-Cell Lung · Austria, Germany, Greece and more | 2 | Completed | May 2011 | 113 |
| NCT00789373Carcinoma, Non-Small-Cell Lung · Australia, Belgium, Finland and more | 3 | Completed | Jun 2010 | 939 |
| NCT00762034Carcinoma, Non-Small-Cell Lung · United States | 3 | Completed | Apr 2012 | 939 |
| NCT00686959Carcinoma, Non-Small-Cell Lung · United States, Argentina, Australia and more | 3 | Completed | Oct 2014 | 598 |
| NCT00606021Carcinoma, Non-Small-Cell Lung · Egypt, Lebanon, Saudi Arabia | 2 | Completed | Dec 2010 | 106 |
| NCT00550173Carcinoma, Non-Small-Cell Lung · Brazil, China, Hong Kong and more | 2 | Completed | Jan 2012 | 247 |
| NCT00529100Carcinoma, Non-Small-Cell Lung · Canada | 2 | Completed | Aug 2010 | 49 |
| NCT00523419Osteosarcoma · France, Germany, Italy and more | 2 | Completed | Jun 2009 | 32 |
| NCT00520936Osteosarcoma · United States | 2 | Completed | Feb 2010 | 72 |
| NCT00520676Carcinoma, Non-Small-Cell Lung · Australia, Brazil, China and more | 3 | Completed | Jul 2010 | 260 |
| NCT00494026Small Cell Lung Carcinoma · Italy, Poland, Spain and more | 2 | Terminated | Oct 2008 | 4 |
| NCT00490373Pancreatic Neoplasms · Germany | 2 | Completed | 52 | |
| NCT00489983Carcinoma, Non-Small-Cell Lung · Germany, Italy, United Kingdom | 2 | Completed | 91 | |
| NCT00489359Ovarian Neoplasms · Argentina, Canada, Germany and more | 2 | Completed | Feb 2010 | 86 |
| NCT00475657Small Cell Lung Carcinoma · Spain | 2 | Terminated | Apr 2008 | 5 |
| NCT00461786Ovarian Neoplasms · United States | 2 | Completed | Oct 2007 | 51 |
| NCT00447421Small Cell Lung Carcinoma · Belgium, Netherlands | 2 | Terminated | May 2008 | 9 |
| NCT00447057Histological or Cytological Diagnosis of Locally Advanced or Metastatic NSCLC of Nonsquamous Histology and Not Amenable to Curative Therapy. · Austria, Germany, Hungary and more | 2 | Completed | Jul 2010 | 204 |
| NCT00415194Head and Neck Neoplasms · United States, Argentina, Belgium and more | 3 | Completed | Mar 2010 | 795 |
| NCT00415168Stomach Neoplasms · Russian Federation | 2 | Completed | Jul 2009 | 53 |
| NCT00409006Carcinoma, Non-Small-Cell Lung · China, Korea, Republic of, Taiwan | 2 | Completed | Aug 2009 | 70 |
| NCT00391274Carcinoma, Non-Small-Cell Lung · China | 3 | Completed | Dec 2008 | 211 |
| NCT00386815Mesothelioma, Malignant · Japan | 2 | Completed | 20 | |
| NCT00383331Carcinoma, Non-Small-Cell Lung · United States | 2 | Terminated | Jan 2008 | 19 |
| NCT00380718Carcinoma, Non-Small-Cell Lung · Taiwan | 4 | Completed | Sep 2008 | 33 |
| NCT00377520Neoplasms · United States | 2 | Completed | Oct 2007 | 27 |
| NCT00374868Urologic Neoplasms · Spain | 2 | Completed | Apr 2008 | 59 |
| NCT00370292Carcinoma, Non-Small-Cell Lung · Italy | 2 | Completed | Sep 2008 | 19 |
| NCT00363415Small Cell Lung Carcinoma · United States, Argentina, Australia and more | 3 | Completed | Jun 2008 | 908 |
| NCT00356525Lung Neoplasms · United States, Brazil, India | 2 | Terminated | Jun 2008 | 41 |
| NCT00350792Carcinoma, Non-Small-Cell Lung · France | 2 | Completed | Nov 2008 | 62 |
| NCT00330915Rectal Neoplasms · Sweden | 2 | Completed | Jun 2008 | 37 |
| NCT00325234Breast Neoplasms · Germany, Italy, South Africa and more | 2 | Completed | Apr 2010 | 135 |
| NCT00320515Stomach Neoplasms · Argentina, Mexico, South Korea and more | 2 | Completed | Jul 2008 | 89 |
| NCT00316225Carcinoma, Non-Small-Cell Lung · Denmark, Germany, Spain | 2 | Completed | Mar 2009 | 31 |
| NCT00308750Carcinoma, Non-Small-Cell Lung · United States | 2 | Completed | Jul 2009 | 218 |
| NCT00259285Carcinoma, Non-Small-Cell Lung · Spain | 2 | Terminated | Dec 2007 | 10 |
| NCT00251550Malignant Pleural Mesotherioma · Japan | 2 | Completed | 12 | |
| NCT00192088Advanced Gastric Carcinoma · Italy | 2 | Completed | 43 | |
| NCT00191984Colorectal Neoplasms · France | 2 | Completed | Feb 2007 | 46 |
| NCT00191750Carcinoma, Small Cell · United States | 2 | Completed | 80 | |
| NCT00191503Adenocarcinoma · Canada | 2 | Completed | 30 | |
| NCT00191412Liver Neoplasms · United States | 2 | Completed | 41 | |
| NCT00191347Breast Neoplasms · Canada | 2 | Completed | 30 | |
| NCT00191308Carcinoma, Non-Small-Cell Lung · Poland | 2 | Completed | Jul 2008 | 30 |
| NCT00191191Carcinoma, Non-Small-Cell Lung · Japan | 2 | Completed | Oct 2008 | 226 |
| NCT00190983Uterine Cervical Dysplasia · United States | 2 | Completed | Oct 2007 | 29 |
How it is read
Names in the registry
- “Pemetrexed”, 74 entries
- “pemetrexed”, 51 entries
- “ALIMTA”, 7 entries
- “Pemetrexed/Cisplatin”, 2 entries
- “Pemetrexed/Carboplatin”, 2 entries
Conditions, from the studies’ own filings
- Carcinoma, Non-Small-Cell Lung, 73 studies
- Breast Neoplasms, 9 studies
- Neoplasms, 5 studies
- Ovarian Neoplasms, 4 studies
- Colorectal Neoplasms, 4 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.